Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

31.98 -2.56 (-7.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 680,400
Open 33.50
Bid (Size) 31.60 (3)
Ask (Size) 32.45 (1)
Prev. Close 34.54
Today's Range 31.50 - 34.69
52wk Range 6.760 - 137.25
Shares Outstanding 7,324,670
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Jim Hunter to Board of Directors
Via Investor Brand Network
Exposures Product Safety
Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble
Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company's lead drug candidate is for the management of fibromyalgia pain. 
Via Benzinga

Performance

YTD
+1.8%
+1.8%
1 Month
+58.5%
+58.5%
3 Month
+134.5%
+134.5%
6 Month
+39.7%
+39.7%
1 Year
-71.2%
-71.2%

More News

Read More
Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic
Via Stocktwits
Exposures Product Safety
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 BIO International Convention
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at EULAR 2025 in Barcelona
Via Investor Brand Network
Exposures Product Safety
What's Going On With Tonix Pharmaceuticals Stock?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins A.G.P. Healthcare Showcase Fireside Chat
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Doses First Patient in DoD-Backed OASIS Trial for Acute Stress Reaction
Via Investor Brand Network
Exposures Product Safety
The market is filled with gapping stocks in Friday's session.
Via Chartmill
Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive
Via Stocktwits
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
Via Investor Brand Network
Exposures Product Safety
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data for TNX-1700 at AACR 2025
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Showcases Single-Dose Mpox Vaccine Data at World Vaccine Congress
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Collaborates With Makana Therapeutics on Xenotransplantation Research
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Data on Fibromyalgia Drug at AAPM 2025
Via Investor Brand Network
Exposures Product Safety
Peering Into Tonix Pharmaceuticals's Recent Short Interest
Via Benzinga
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at 2025 Jones Trading Healthcare Conference
Via Investor Brand Network
Exposures Product Safety

Frequently Asked Questions

Is Tonix Pharmaceuticals Holding Corp. - Common Stock publicly traded?
Yes, Tonix Pharmaceuticals Holding Corp. - Common Stock is publicly traded.
What exchange does Tonix Pharmaceuticals Holding Corp. - Common Stock trade on?
Tonix Pharmaceuticals Holding Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock?
The ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock is TNXP on the Nasdaq Stock Market
What is the current price of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock is 31.98
When was Tonix Pharmaceuticals Holding Corp. - Common Stock last traded?
The last trade of Tonix Pharmaceuticals Holding Corp. - Common Stock was at 06/13/25 04:00 PM ET
What is the market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock is 234.24M
How many shares of Tonix Pharmaceuticals Holding Corp. - Common Stock are outstanding?
Tonix Pharmaceuticals Holding Corp. - Common Stock has 234M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.